CPIG
CUE icon

Chicago Partners Investment Group’s Cue Biopharma CUE Stock Holding History

Chicago Partners Investment Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,865
Closed -$49.9K – 1616
2026
Q1 		$49.9K Hold
2,865
– – ﹤0.01% 1422
2025
Q4 		$32.7K Hold
2,865
– – ﹤0.01% 1287
2025
Q3 		$63.5K Sell
2,865
-78
-3% -$1.83K ﹤0.01% 1196
2025
Q2 		$78.6K Sell
2,943
-67
-2% -$1.43K ﹤0.01% 1071
2025
Q1 		$69.4K Buy
+3,010
New +$112K ﹤0.01% 909

Other funds holding CUE

RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Chicago Partners Investment Group's CUE Position: Q2 2026 in Review

Chicago Partners Investment Group sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 2,865 shares — an estimated $49.9K sold.

Chicago Partners Investment Group first reported a position in CUE in Q1 2025 and held it in 5 quarters. The position peaked at $78.6K in Q2 2025. 8 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Chicago Partners Investment Group reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 2,865 Cue Biopharma shares in Q2 2026, an estimated $49.9K.
  • Chicago Partners Investment Group first reported a position in Cue Biopharma in Q1 2025 and held it in 5 quarters.
  • Chicago Partners Investment Group's Cue Biopharma position peaked at $78.6K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.